We are live on
!
Find out more
Marshall Wace North America Portfolio holdings
AUM
$23.5B
Turnover
51.87%
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+18.68%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.1B
AUM Growth
+$3.8B
(+37%)
Cap. Flow
+$2.04B
Cap. Flow
% of AUM
14.45%
Top 10 Holdings %
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.6
years
Top 20 Avg Time Held Equity + Options
0.7
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$188M |
| 2 |
Amazon
AMZN
|
+$137M |
| 3 |
Adobe
ADBE
|
+$110M |
| 4 |
Electronic Arts
EA
|
+$110M |
| 5 |
Pfizer
PFE
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$131M |
| 2 |
Microsoft
MSFT
|
+$129M |
| 3 |
Visa
V
|
+$119M |
| 4 |
Booking.com
BKNG
|
+$86M |
| 5 |
Humana
HUM
|
+$82.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.92% |
| 2 | Technology | 15.98% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Industrials | 8.63% |
| 5 | Financials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Zoetis
ZTS
$32.8B
| $381M | 2.69% |
3,779,770
+325,829
| +9% | +$29.6M |
2013 Q2
23 quarters
|
|
2
Boston Scientific
BSX
$64.3B
| $346M | 2.44% |
9,002,670
+2,494,598
| +38% | +$95.3M |
2017 Q1
8 quarters
|
|
|
3
Pfizer
PFE
$169B
| $316M | 2.23% |
7,833,301
+2,710,494
| +53% | +$109M |
2013 Q2
23 quarters
|
|
4
DELISTED
Sealed Air
SEE
| $283M | 2% |
6,143,862
+144,425
| +2% | +$6M |
2017 Q1
8 quarters
|
|
5
Danaher
DHR
$161B
| $279M | 1.98% |
2,386,214
+779,264
| +48% | +$79.9M |
2013 Q4
21 quarters
|
|
|
6
Amazon
AMZN
$2.7T
| $267M | 1.89% |
2,994,840
+1,645,280
| +122% | +$137M |
2013 Q3
22 quarters
|
|
7
UnitedHealth
UNH
$360B
| $244M | 1.72% |
985,340
-81,931
| -8% | -$20.9M |
2017 Q1
8 quarters
|
|
8
Alphabet (Google) Class A
GOOGL
$4.17T
| $232M | 1.64% |
3,937,120
-1,391,860
| -26% | -$78.6M |
2017 Q1
8 quarters
|
|
9
Merck
MRK
$360B
| $227M | 1.61% |
2,864,455
+418,038
| +17% | +$31.3M |
2017 Q1
8 quarters
|
|
|
10
Fidelity National Information Services
FIS
$18.6B
| $201M | 1.42% |
1,774,196
+1,762,979
| +15,717% | +$188M |
2018 Q4
1 quarter
|
|
|
11
Adobe
ADBE
$95.4B
| $198M | 1.4% |
742,342
+437,154
| +143% | +$110M |
2013 Q3
22 quarters
|
|
12
US Foods
USFD
$22.1B
| $190M | 1.34% |
5,435,138
+481,614
| +10% | +$16.5M |
2017 Q4
5 quarters
|
|
13
DELISTED
Berry Global Group, Inc.
BERY
| $190M | 1.34% |
3,834,806
+176,684
| +5% | +$8.38M |
2013 Q4
21 quarters
|
|
|
14
Microsoft
MSFT
$3.93T
| $183M | 1.3% |
1,552,503
-1,183,132
| -43% | -$129M |
2017 Q1
8 quarters
|
|
15
Vulcan Materials
VMC
$33.4B
| $170M | 1.2% |
1,436,892
+219,174
| +18% | +$23.7M |
2017 Q1
8 quarters
|
|
16
S&P Global
SPGI
$127B
| $159M | 1.12% |
754,119
+66,389
| +10% | +$12.9M |
2017 Q1
8 quarters
|
|
17
Carlisle Companies
CSL
$13.3B
| $151M | 1.07% |
1,227,891
-79,091
| -6% | -$9.13M |
2017 Q1
8 quarters
|
|
18
Teleflex
TFX
$5.53B
| $150M | 1.06% |
494,782
+120,411
| +32% | +$33.6M |
2017 Q1
8 quarters
|
|
19
Vertex Pharmaceuticals
VRTX
$127B
| $146M | 1.03% |
792,007
+291,952
| +58% | +$53.9M |
2017 Q1
8 quarters
|
|
20
Boeing
BA
$150B
| $145M | 1.03% |
380,099
+172,305
| +83% | +$66.3M |
2017 Q1
8 quarters
|
|
21
GoDaddy
GDDY
$13.4B
| $139M | 0.98% |
1,843,567
-9,313
| -0.5% | -$655K |
2017 Q1
8 quarters
|
|
22
Ascendis Pharma A/S
ASND
$14.8B
| $137M | 0.97% |
1,161,476
+418,717
| +56% | +$36.7M |
2017 Q1
8 quarters
|
|
23
PTC
PTC
$21B
| $135M | 0.96% |
1,465,385
+179,090
| +14% | +$15.9M |
2017 Q1
8 quarters
|
|
|
24
DELISTED
Electronic Arts
EA
| $128M | 0.91% |
1,263,601
+1,157,504
| +1,091% | +$110M |
2017 Q2
7 quarters
|
|
25
Quest Diagnostics
DGX
$25.9B
| $120M | 0.85% |
1,332,250
-235,820
| -15% | -$20.4M |
2017 Q1
8 quarters
|
|
Similar funds
NAM
Marshall Wace North America's Q1 2019 Portfolio in Review
As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace North America deployed $2.04B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.
- Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
- Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
- Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
- Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
- Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
- Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
- Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.
Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.